Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Quest Patent Research (QPRC) EBT (2016 - 2025)

Quest Patent Research's EBT history spans 15 years, with the latest figure at -$1.2 million for Q3 2025.

  • For Q3 2025, EBT fell 106.31% year-over-year to -$1.2 million; the TTM value through Sep 2025 reached -$4.2 million, down 209.02%, while the annual FY2024 figure was -$2.4 million, 202.74% down from the prior year.
  • EBT for Q3 2025 was -$1.2 million at Quest Patent Research, down from -$1.1 million in the prior quarter.
  • Across five years, EBT topped out at $5.2 million in Q4 2023 and bottomed at -$5.2 million in Q1 2021.
  • The 5-year median for EBT is -$596352.0 (2024), against an average of -$429864.5.
  • The largest annual shift saw EBT soared 1656.77% in 2021 before it tumbled 903.83% in 2023.
  • A 5-year view of EBT shows it stood at $823008.0 in 2021, then plummeted by 159.38% to -$488735.0 in 2022, then soared by 1168.22% to $5.2 million in 2023, then plummeted by 119.19% to -$1.0 million in 2024, then decreased by 22.81% to -$1.2 million in 2025.
  • Per Business Quant, the three most recent readings for QPRC's EBT are -$1.2 million (Q3 2025), -$1.1 million (Q2 2025), and -$826385.0 (Q1 2025).